Phospho-CRK (Tyr221) Recombinant Antibody, APC-Cy7 Conjugated
Product Specifications
Background
The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling.
Synonyms
Adapter molecule crk; avian sarcoma virus CT10 (v-crk) oncogene homolog; CRK; CRKII; Proto-oncogene c-Crk.
Gene ID
1398
Swiss Prot
P46108
Modification Site
Tyr221
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
CRK (Tyr221)
Clonality
Recombinant
Isotype
IgG
Conjugation
APC-Cy7
Source
KLH conjugated synthetic peptide derived from human CRK around the phosphorylation site of Y221
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
650nm/780nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1398
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPC28792-01 20 µg
Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S) (D614G), partial, Active Protein
Ask
View Details 
RPC28792-02 100 µg
Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S) (D614G), partial, Active Protein
Ask
View Details RPC28792-03 1 mg
Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S) (D614G), partial, Active Protein
Ask
View Details GTR15303165 1 Vial
Lentiviral human AIFM2 shRNA (UAS) - Lentiviral human AIFM2 shRNA (UAS) (100)
Ask
View Details